The GBT Foundation

Building on GBT’s corporate giving commitment, The GBT Foundation is a community-focused, charitable entity that seeks to improve the health and well-being of underserved patient communities around the world, particularly for people living with SCD.

Founded in 2021, The GBT Foundation is a separate legal entity from GBT, Inc. The GBT Foundation is primarily funded by GBT, Inc., and is committed to giving back to the communities we serve through funding and collaboration.

Areas of Giving

The GBT Foundation partners with nonprofit organizations to support programs around the world that have the potential to create meaningful and sustainable change. The GBT Foundation is focused on advancing health equity through education, empowerment, and innovation for people living with serious blood disorders, starting with SCD.

The GBT Foundation seeks to advance programs that address our key focus areas:

  • Increasing education and awareness for communities impacted by SCD to build knowledge of the devastating physical, social, mental and societal effects of this genetic blood disorder..
  • Empowering people with SCD, caregivers and others in the SCD community to help improve the lives and care of the community.
  • Improving access to healthcare to ensure those living with SCD receive the high-quality health services they need and deserve.
  • Enhancing health equity through innovative and sustainable solutions that help vulnerable communities have the chance to reach their full health potential without social obstacles.

How to Apply

The GBT Foundation invites nonprofit organizations to apply for funding for eligible programs through our web-based grants process. Applications will be evaluated on their potential to advance The GBT Foundation’s mission in its core focus areas. We are currently accepting applications from not-for-profit organizations around the world. In the U.S., applicants must be registered as 501(c)(3) public charities.

Committed to ACCELerating progress

The focus areas of The GBT Foundation build on GBT’s previous corporate giving programs, some of which are now housed within The GBT Foundation. Since 2019, GBT’s Access to Excellent Care for Sickle Cell Patients (ACCEL) Grant Program has provided funding to U.S.-based nonprofit organizations that serve patients with SCD and their families and seek to improve their access to high-quality healthcare.

Over its first three years, in total the ACCEL program funded nearly $1 million to 19 organizations to accelerate the development of sustainable and innovative programs. Beginning in 2022, ACCEL grants will be funded by The GBT Foundation.

Priority areas for ACCEL grant proposals include educational initiatives focused on patient empowerment, shared decision-making and enabling navigation of the healthcare system; improving transition from pediatric to adult care; community outreach models using health workers to directly facilitate access to care; innovative training programs and outreach models; and initiatives that address racial equity and COVID-19 vaccine awareness amongst the SCD community.